USPTO serial 87548951
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory S. Bernabeo
Gregory S. Bernabeo FisherBroyles, LLP1650 Market Street36th FloorPhiladelphia, PA 19103| Class | Description | Status | First use |
|---|---|---|---|
| 001 | antibodies for purification purposes, for laboratory or scientific research use; antibodies for commercial use, namely, for industrial, scientific or research use; antibodies for commercial use, namely, for medical laboratory use; enzymes for scientific and research purposes; monoclonal antibodies for in vitro scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; cell cultures for laboratory and scientific research use; nucleic acid sequences for laboratory and scientific research use; cloning vehicles in the nature of plasmids and recombinant nucleic acid variations thereof for in vitro and in vivo laboratory and scientific research use | ABANDONED | — |
| 042 | genetic engineering services, namely, scientific and medical research in the field of genetic engineering; biotechnology services, namely, research and development for new products in the field of biotechnology; scientific and technological services, namely, research and development in the field of design and development of biologic molecules, recombinant expression products, and drug products with a particular emphasis on proteins that are secreted by cells; scientific development services in the field of antibodies, namely, custom antibody production, development and generation for others; scientific laboratory services, namely, performing hybridoma cell line development; scientific research and development, namely, development of antibodies for others; scientific, technological and medical research services, namely, providing protein expression, antibody production, cell line establishment, cell culture production of proteins, and hybridoma development for scientific and medical research use | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2018 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Nov 30, 2018 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Nov 28, 2018 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jun 26, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 13, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 5, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 5, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 16, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 28, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 24, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 19, 2018 | ALIE | ASSIGNED TO LIE | — |
| Apr 10, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 10, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 5, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 3, 2017 | NWAP | NEW APPLICATION ENTERED | — |